These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


445 related items for PubMed ID: 34304627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
    Almalki AH, Alrowaie FA, Alhozali HM, Almalki NK, Alsubei AI, Alturki MS, Sadagah LF.
    Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
    [Abstract] [Full Text] [Related]

  • 5. Outcome of childhood lupus nephritis in Saudi children.
    Al-Mayouf SM, AlAmeer A, Alfattani A, Alsonbul A.
    Saudi J Kidney Dis Transpl; 2017 Aug; 28(5):1015-1020. PubMed ID: 28937057
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1069-1077. PubMed ID: 33826705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.
    Lupus; 2014 Feb 25; 23(2):159-65. PubMed ID: 24300780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
    Yadav S, Balakrishnan C, Mangat G, Kothari J.
    Lupus; 2024 Jan 25; 33(1):88-95. PubMed ID: 38048588
    [Abstract] [Full Text] [Related]

  • 14. Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.
    Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J, Kim YG, Huh WS, Seo J, Koh EM, Cha HS.
    Rheumatol Int; 2012 Jul 25; 32(7):1877-84. PubMed ID: 21442173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
    Yang TH, Wu TH, Chang YL, Liao HT, Hsu CC, Tsai CY, Chou YC.
    Clin Nephrol; 2018 Apr 25; 89(4):277-285. PubMed ID: 29319493
    [Abstract] [Full Text] [Related]

  • 17. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
    Li C, Han Y, Zhang L, Chen Z, Jin M, Sun S.
    BMC Nephrol; 2022 Aug 26; 23(1):296. PubMed ID: 36008770
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early-stage predictors for treatment responses in patients with active lupus nephritis.
    Liu G, Wang H, Le J, Lan L, Xu Y, Yang Y, Chen J, Han F.
    Lupus; 2019 Mar 26; 28(3):283-289. PubMed ID: 30682900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.